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In the humoral immune response to most antigens studied so far, the presence of  helper 
T cells is required for the generation of antibody-forming cells from precursor B cells. In 
terms of the classical carrier-hapten systems described by Mitchison (1), B cells specific 
for a hapten can only become antibody-forming cells if helper T cells react with antigenic 
determinants on the carrier molecule that the hapten is linked to. This finding has later 
on led to the hypothesis that the close proximity brought about by an antigen "bridge" 
between B cell and T cell is the prerequisite for T-B cooperation (2). Under this assump- 
tion,  several  concepts have been developed to explain  the nature of T-cell help itself. 
Among these are: the focussing of  antigen by the T cell onto the B cell (2, 3), a membrane 
interaction between the two cells (4), and the production of  mediators, antigen specific (5- 
7) or nonspecific (4, 7-14), by the antigen-stimulated T cell. In vitro studies have shown 
that T-cell-replacing factor (TRF),I a nonantigen-specific mediator produced by activated 
T cells (15), can replace T cells in primary and secondary immune responses to heterolo- 
gous erythrocytes (15, 16). The action of TRF and similar factors described  by other 
authors (4,  7-14) has so far been demonstrated by restoring the immune response  to 
heterologous erythrocytes in T-cell-deprived cultures by addition of  preparations contain- 
ing the factor.  On the other hand, the experiments  reported by Hartmann (17) have 
shown that T cells activated to erythrocyte antigens in vivo do, upon antigenic challenge 
in vitro,  not only restore  the response  of B-cell cultures to the epitopes of the same 
erythrocytes, but also to those of  erythrocytes  from another species added simultaneously 
to the same cultures.  Although this co-stimulation  is best  explained  by the  in situ 
generation and action of TRF, the function, and indeed the presence of this mediator in 
complete spleen cell cultures during the immune response remains to be demonstrated. 
In order to study this question under the most stringent conditions, we chose 
the anamnestic IgG reaction to soluble carrier-hapten conjugates in vitro. The 
pronounced T-cell dependence of the IgG response to such a  conjugate and the 
possibility to stimulate T and B cells separately with carrier and hapten deter- 
minants  make  it  possible  to  investigate the  action  of TRF  in  the  immune 
response to soluble protein antigens. 
* This investigation was supported by Sonderforschungsbereich 105, Wtirzburg. 
1  Abbreviations  used  in  this paper:  BSS, Hanks' balanced salt solution; DNP, dinitrophenyl; 
FDNB, fluorodinitrobenzene;  GPC, guinea pig complement; HRBC, horse red blood cells; KLH, 
keyhole limpet hemocyanin; OVA, ovalbumin; PFC, plaque-forming cells; TRF, T-cell-replacing 
factor. 
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Materials and Methods 
Mice.  DBA/2  mice  were  obtained  from  Bomholtgard,  Ry,  Denmark.  Mice  of both  sexes 
between 6 wk and 6 mo of age were used. 
Antigens.  Soluble protein antigens were Keyhole limpet hemocyanin  (KLH), dinitrophenyl 
KLH  (312 DNP groups per  10  ~ mol wt),  DNPBGG  (310  DNP groups per  10  ~ mol wt),  all from 
Calbiochem, San Diego, Calif.), and DNPOVA (194 DNP groups per I(P mol wt). The latter was 
prepared as described in reference 18 by reacting Ovalbumin  (OVA)  {Sigma Chemical Co., St. 
Louis, Mo.) in 0.05 M  NaHCO.~ with fluorodinitrobenzene (FDNB) in dioxane. After exhaustive 
dialysis  against  water,  the  product  was  lyophilized.  The  hapten  Gly2-DNP was  prepared  by 
reacting Gly-Gly in 0.05 M NaHCO.~ with an excess of FDNB in ethanol according to Sanger (19). 
Immunizations.  Mice were primed 6-14 wk before use with an intraperitoneal (i.p.) injection 
of 200 ~tg alum-precipitated protein and 10  ~ Bordetella pertussis organisms (Behringwerke, Mar- 
burg-Lahn,  W. Germany).  Boosting was performed by an i.p. injection of 20/~g soluble protein. 
DNPKLH-primed mice were boosted 7 days before use.  KLH-specific helper cells were taken 3 
days after boosting of KLH-primed mice; in agreement with other authors  (20),  better helper 
activity could be obtained than after a  7-day boost. 
Tissue Culture.  Spleen cell cultures were prepared as described by Mishell and Dutten  (21) 
and cultured in Eagle's minimal essential medium (MEM) for normal cultures  (Microbiological 
Associates, Inc., Bethesda, Md.). 5 ×  10  ~ nucleated cells in 0.5 ml of culture medium containing 5 
x  10 -5 M 2-mercaptoethanol, 5% fetal calf serum (Armour Pharmaceutical Co., Chicago, Ill.), and 
supplemented as given in reference 21 were seeded into tissue culture plates (Costar, Cambridge, 
Mass.) with 24 flat-bottom holes (15-ram diameter).  One drop of a  nutritional cocktail  (21) was 
added on each day of culture.  Cultures were harvested at the times indicated,  washed once in 
Hanks' balanced salt solution (BSS) and resnspended in the appropriate dilutions for the plaque 
assay. 
Anti-Thy 1.2 Treatment of Spleen Cells.  Anti-Thy 1.2 ascitic fluid was prepared according to 
Raft (22) by 6 wk i.p. injections of 107 CBA thymus cells into AKR mice (The Jackson Laboratories, 
Bar Harbor, Maine). Together with the last injection, 0.1 ml of a 1:10 dilution of freshly harvested 
mouse Krebs II ascites cells were injected. The ascitic fluid was collected i wk later. For removal of 
T cells, 6 × 107 spleen cells were kept in i ml of this fluid at a dilution of 1:3 in medium for 30 min 
on  ice.  Cells  were  washed  and  resuspended  in  the  same  volume of agarose-absorbed  rabbit 
complement at a  dilution of 1:5 in medium,  incubated for 45 rain at 37°C,  washed twice, resus- 
pended in medium, and adjusted to the appropriate concentration. 
Assay for A nti-DNP PFC.  The Jerne hemolytic plaque assay was used as modified by Mishell 
and Dutton (21). Horse red blood cells (HRBC) were sensitized with 2,4,6-trinitrobenzene sulfonic 
acid as described by Rittenberg and Pratt (23). HRBC were always taken from the same horse and 
showed only neglegible background  plaque-forming cells (PFC).  After plating,  the slides were 
covered with BSS and incubated for 90 min at 37°C.  The BSS was then replaced by guinea pig 
complement (GPC) diluted 1:15 in BSS and incubated for another 90 rain. At this point, IgM-PFC 
were  recorded and  the  slides  reincubated  with  a  1:75 dilution  of rabbit  anti-mouse  Ig serum 
(Behringwerke)  in  diluted  GPC  for 45  rain.  Again,  the hemolytic plaques  were counted.  The 
difference between the two counts, i.e., the "indirect" PFC, will be referred to as IgG-PFC in this 
paper. This evaluation seems reliable to us because (a) the number of IgG-PFC in positive cultures 
was  always about  10 times higher than the number  of IgM-PFC, and  (b)  cultures from KLH- 
primed cells, upon incubation with DNPKLH, showed few IgM but absolutely no IgG-PFC. The 
number  of recovered nucleated cells was determined  in a  Coulter Counter  (model FN,  Coulter 
Electronics, Inc., Hialeah, Fla.), using Zaponin  (Coulter Electronics, Inc.) to lyse red cells. Re- 
suits will be given as anti-DNP IgG-PFC per million recovered nucleated cells (IgG-PFC/10~). 
Results 
Recently, North and Askonas have described an in vitro system (24) in which 
very high responses to DNPKLH can be obtained. Just as in the anamnestic 
response in vivo, the vast majority of anti-DNP-PFC induced in these cultures 
produce IgG antibodies,  whereas IgM-PFC  represent  only  10-15%  of the re- 
sponse. As the IgG response is known to be even more sensitive to the removal of 
T cells than is the primary, predominantly IgM response (25), we have used this 1218  IN  SITU  ACTION  OF  T-CELL-REPLACING  FACTOR 
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FXG. I.  Dose-response relationship  of  the  IgG-response to  DNPKLH  in  vitro.  Spleen  cells 
from mice primed and boosted with DNPKLH  were cultured  in  the presence of  increasing 
concentrations  of  DNPKLH.  Anti-DNP PFC were tested  on day 5 of  culture. 
system for  a study  on  the production and action  of  TRF in  the response to  soluble 
protein antigens. The same immunization schedule was used as described by 
North and Askonas (24),  and tissue  cultures  were set  up as described  in  Materi- 
als  and Methods. Fig. I  shows a  typical  dose-response  profile  of  spleen  cells  from 
DNPKLH  primed and boosted mice aider  5  days of  culture.  The optimal concen- 
tration  of  DNPKLH  varied between 0.01  and 0.1 fig  DNPKLH  per culture,  and 
the response was sometimes as  high as  30,000  IgG-PFC/106. Thus, the  properties 
of  the system as reported by North and Askonas could be fully  reproduced. 
To characterize this response as a classical  carrier-hapten system, it was 
investigated  if  the  recognition  of  the DNP moiety by  the B cells  could  be  blocked 
by free  hapten and if, on the other side,  the recognition  of  the KLH  moiety by 
helper T cells  could be blocked by free carrier.  Fig. 2 shows that, quite in 
agreement with other authors who employed heterologous  carrier-hapten  conju- 
gates (26-30),  we found that  the response could  be  easily  blocked by  the addition 
of  free  hapten. The presence of  4 fig  GIy2DNP resulted  in  a 85% reduction  of  the 
response to  0.01  pg  DNPKLH,  and  with 16 pg  GIy2DNP, background levels  were 
reached. In parallel experiments  it was found that the concentrations of 
GIy2DNP used were not  toxic  for  the cultures,  as the primary response to sheep 
red blood cells  (SRBC) was unimpaired,  and higher doses of GIy2DNP were 
required to block higher concentrations  of  DNPKLH  (data  not shown). 
On the other  hand, we were unable to  block  T-cell  help by  increasing  amounts 
of "free"  carrier  (Fig.  3). At 4 fig KLH  per culture, a concentration 400-fold 
higher than that of  DNPKLH,  we observed even a stimulation of  the response, 
and at higher concentrations the values were still  at control levels  without 
KLH. Here it  seems obvious that the KLH-primed helper cells  do not have to 
recognize  KLH on  the same molecule that  binds to  and stimulates  the B cells  via 
the DNP-specific antigen receptor  to  exert  their  helper function.  This  point  was TH.  HONIG,  A.  SCHIMPL,  AND  E.  WECKER 
IgG-PFC/106 
1219 
200~ 
1500- 
1000" 
500. 
BG  I,  I  I 
,e 
o  ~  ~  ~  ~  16 
~ug Gly2DNP/culture 
FzG.  2.  Inhibition of the IgG response to DNPKLH by free hapten. Spleen cells from mice 
primed and boosted with DNPKLH were cultured in the presence of 0.01 ~tg DNPKLH and 
increasing amounts of the hapten Gly2DNP. Anti-DNP IgG-PFC were tested on day 5 of 
culture. 
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FIG.  3.  Failure to inhibit the IgG response to DNPKLH by free carrier. Spleen cells from 
mice primed and boosted with DNPKLH were cultured in the presence of 0.01 ~g DNPKLH 
and increasing amounts of KLH. Anti-DNP IgG-PFC were tested on day 5 of culture. 1220  IN  SITU  ACTION  OF  T-CELL-REPLACING  FACTOR 
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FIG.  4.  Stimulation of  the  anamnestic anti-hapten IgG  response by  simultaneous addition 
of  a heterologous carrier-hapten conjugate and free  homologous carrier.  Spleen cells  from 
mice primed and  boosted with DNPKLH  were cultured with increasing amounts of  KLH in 
the presence  (e----e)  or absence (©--O) of 0.1 /~g DNPBGG.  The response  to 0.1 /~g 
DNPKLH  in the same experiment is included for comparison.  Cultures were assayed for 
anti-DNP IgG-PFC on day 5. 
now tested by presenting the hapten to the B cell on a heterologous carrier while 
stimulating the KLH-reactive helper cells by free KLH. Fig. 4 shows such an 
experiment. Spleen cell cultures from mice primed and boosted with DNPKLH 
were stimulated either with DNPBGG or with KLH,  or with both antigens. 
While either antigen alone failed to stimulate a significant anti-DNP response 
in these cultures, the combined addition of DNPBGG and KLH resulted in a 
response almost as high as that elicited by DNPKLH itself. Moreover, a clear 
dose  dependency for  the  stimulation  of KLH-specific helper  cells  could  be 
observed,  with  a  maximum response at  1  /~g KLH.  This  cooperative effect 
between T and B cells without a bridging antigen molecule is very reproducible 
and can also be observed when the DNP determinants are presented to the B 
cells on  still  another carrier,  e.g.,  OVA.  Table  I  shows  three independent 
experiments in which DNPKLH-primed and boosted spleen cells were stimu- 
lated in vitro by the combined addition of 1 /~g KLH and 0.1  ~g DNPBGG or 
DNPOVA. These findings are most easily explained by assuming the action of a 
nonantigen-specific mediator (TRF) (15), which is produced by the KLH-primed 
T cells (7, 10, 13) upon the reaction with KLH and which helps the DNPBGG or 
DNPOVA-stimulated B cells in the production of anti-DNP antibodies. A simi- 
lar effect  has been described by Hartmann (17) in the primary reaction of B cells 
to heterologous erythrocytes in vitro, and the reconstitution of the anti-SRBC 
reaction of T-cell-deprived spleen cells by TRF  or similar nonspecific T-cell 
factors is well established (4, 8-15), both in the primary and in the secondary 
(16) in vitro responses. IfTRF should be identical with the mediator active in the 
system described here,  it  is  important to  demonstrate that,  like TRF,  it  is 
produced by the activated T cells. This is clearly confirmed by the results shown 
in Fig. 5 and Table II. In beth experiments, treatment of DNPKLH-primed and TH.  HUNIG,  A.  SCHIMPL,  AND  E.  WECKER 
TABLE  I 
Stimulation of the Anamnestic Anti-Hapten IgG Response by 
Simultaneous Addition of a Heterologous  Carrier-Hapten 
Conjugate and Homologous Carrier 
Exp.  I  Exp. II  Exp.  III 
No addition  189  106  292 
0.1 ~g DNPKLH  11,533  6,684  27,798 
0.1 /~g DNPBGG  528  250  674 
1 pg KLH  747  433  901 
0.1 ~g DNPBGG +  1 ~g KLH  6,855  5,764  11,400 
0.1 pg DNPOVA  ND  ND  869 
0.1 ~g DNPOVA +  1 ~g KLH  ND  ND  6,889 
Spleen cells from DNPKLH-primed and boosted mice were cultivated in 
the presence of a  heterologous DNP-protein conjugate with or without 
simultaneous  addition  of the  homologous  carrier  KLH.  Results  are 
given as anti-DNP IgG-PFC/10' recovered cells tested on day 5 of cul- 
ture. 
ND, not done. 
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FIG.  5.  Dependence of in situ TRF production on carrier-primed helper T  cells.  Spleen 
cells from DNPKLH-primed and boosted mice were treated with rabbit complement (upper 
frame) or with anti-Thy  1.2 serum and complement (lower frame).  In the second group, 
either 5  x  10  ~ cells were cultured alone or 10  e cells were co-cultivated with 4  x  10  e spleen 
cells from KLH-primed and boosted mice or with 4  x  108 spleen cells from normal mice. 
Antigen concentrations used were:  DNPKLH,  DNPBGG,  and DNPOVA:  0.1  ftg/culture; 
KLH:  1 /~g/culture. Results are expressed as anti-DNP IgG-PFC/106 recovered cells tested 
on day 4 of culture, corrected for the proportion of DNP-primed B cells. 
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TABLE II 
Dependence of In Situ TRF Production on Carrier-Primed T  Cells 
Number and treat- 
ment of DNPKLH-  Number  of KLH  Antigen(s) in culture§  IgG-PFC/10" 
primed and boosted  helper cells$  day 4 
cells* 
5  x  106 C'  -  -  145 
5  ×  106 C'  -  DNPKLH  4,129 
5  x  106 anti-Thy  +  C'  -  -  88 
5  x  106 anti-Thy  +  C'  -  DNPKLH  87 
5  x  10" anti-Thy  +  C'  -  DNPBGG  85 
5  x  10" anti-Thy  +  C'  -  DNPOVA  184 
5  x  10" anti-Thy  +  C'  -  KLH  73 
5  x  106 anti-Thy  +  C'  -  DNPBGG  +  KLH  86 
5  ×  106 anti-Thy  +  C'  -  DNPOVA  +  KLH  153 
106 anti-Thy  +  C'  4  ×  106  DNPKLH  2,69~1 
10" anti-Thy  +  C'  4  ×  106  DNPBGG  +  KLH  3,41711 
10" anti-Thy  +  C'  4  ×  106  DNPOVA  +  KLH  1,73911 
-  5  ×  106  DNPKLH  0 
-  5  x  106  DNPBGG  +  KLH  0 
-  5  x  106  DNPOVA  +  KLH  0 
*  Spleen  cells  from  DNPKLH-primed  and  boosted  mice  were  treated  with  rabbit 
complement  (C') or with anti-Thy 1.2 serum plus complement. 
*  Spleen cells from mice primed and boosted with KLH. 
§  DNPKLH,  DNPBGG,  DNPOVA:  0.1  ~g/culture;  KLH:  1  ~g/culture. 
II  Corrected  for the  proportion  of DNP-primed  B  cells. 
boosted spleen cells with anti-Thy 1.2  serum and complement before  culture 
abolished not only the response to DNPKLH but also the helper effect induced 
by free KLH for B cells stimulated with DNPBGG or DNPOVA. Furthermore, 
the  additior~  of KLH-specific  helper cells  reconstituted  both  the  response  to 
DNPKLH and to the combinations DNPBGG  +  KLH and DNPOVA  +  KLH, 
whereas the addition of unprimed spleen cells had no effect  (Fig.  5).  In both 
experiments,  helper cells alone gave no response  (data in Fig.  5 not shown). 
These experiments demonstrate that antigen-primed T cells can, upon antigenic 
stimulation, produce a  nonspecific mediator,  presumably identical with TRF, 
which  helps  B  cells  stimulated  by  a  soluble  protein  antigen  to  become  7S 
antibody-forming cells. 
Discussion 
It is well documented by numerous reports that in vitro immune responses to 
the T-cell-dependent antigens of heterologous erythrocytes  can be obtained in 
the  absence  of T  cells  if TRF  (8)  or  similar  nonantigen-specific  mediators 
produced by activated T cells  (4,  9-14) are added to the cultures.  It has been 
demonstrated that TRF is produced by T cells (15), that carry the Ly phenotype 
characteristic for helper T cells (31), and that at least functionally very similar 
mediators are produced by antigen-educated T cells upon rechallenge (7, 9, 10, 
13).  There are,  however,  no reports demonstrating the actual involvement of TH.  HUNIG,  A.  SCHIMPL,  AND  E.  WECKER  1223 
TRF in the in vitro immune response of entire mouse spleen cell populations. 
Carrier-hapten systems as the ones employed in this report (24) are well suited 
to study this question, because it is possible to stimulate the carrier-specific cells 
by unhaptenated carrier without stimulating the hapten-reactive B cells. Hap- 
ten-free homologous carrier  or  heterologous carrier-hapten  conjugates have 
been used by several authors  (26-30)  in  attempts to analyze  selectively the 
reactivity of helper T cells and hapten-specific B cells. There is general consen- 
sus that the anti-hapten response can be inhibited by the hapten on a heterolo- 
gous carrier  (26-30).  Correspondingly, our experiments show that during the 
anamnestic response to DNPKLH in vitro the hapten reactive B cells can be 
blocked by GIy2DNP (Fig. 2). Regarding the helper T cells, Bluestein and Pierce 
were  able  to  inhibit  the  primary  immune response  to  TNP~bX  by  adding 
unhaptenated ~bX  (26). This seems to be in contrast to the results presented 
here. In an anamnestic anti-DNPKLH immune response, KLH-specific helper 
cells still provide their helper function in the presence of a  1,000 times higher 
concentration of KLH  than  that  of the  conjugate DNPKLH  (Fig.  3).  This 
seeming discrepancy can be reconciled within the frame work of the original 
Mitchison-Rajewsky model (2) as follows: in case of the primary immune re- 
sponse to TNP~bX (26), relatively few ~bX-specific helper cells are present in the 
cultures. Only if T and B cells are actually linked by the antigen TNP-~bX will 
the B cells receive enough of  the (nonantigen-specific) mediator (TRF) (8), which 
is produced by the helper cell that has reacted with the carrier determinants. 
The  anamnestic response  to  DNPKLH  in  vitro,  however,  is  about  100-fold 
higher in terms of anti-DNP PFC than is the primary response to TNP~bX. 
Quite obviously, and as is shown by the experiments described in this paper, 
there  are  so many KLH-specific helper cells present in these cultures that 
enough helper factor is produced to reach even those B cells that are not linked 
to them by an antigen bridge. This notion was verified by applying experimental 
conditions which exclude an antigen bridge between DNP-reactive B cells and 
KLH-specific T cells; DNPBGG or DNPOVA are able to stimulate the antibody 
response of the DNP-specific B cells if unhaptenated KLH is added simultane- 
ously to stimulate the numerous primed helper T cells (Fig. 4 and Table I). The 
positive outcome of this experiment is in agreement with the observations of 
Hartmann (17) in which the in situ action of a nonantigen-specific helper factor 
produced by  "educated"  T  cells  was  demonstrated in  the  primary  immune 
response to heterologous red blood cells. A similar experiment was described by 
Marrack and Kappler (32) in which KLH-primed spleen cells, upon stimulation 
with  this  antigen,  helped SRBC-stimulated B  cells  in  the  same culture  to 
become IgM hemolysin-producing cells. Kishimoto and Ishizaka (33) described 
an in vitro system consisting of rabbit mesenteric lymph node cells primed with 
DNP-ragweed. It was found that stimulation of  rag-sensitized cells with free rag 
enhanced anti-DNP IgG and IgE responses to  DNP-unrelated carrier  conju- 
gates. Cell-free supernates obtained from cultures of primed lymph node cells 
incubated with free carrier also showed this enhancing effect. These systems are 
comparable to the one employed in this paper with respect to the presence of 
primed helper cells,  and just  as  in  our system, the results  are  most easily 
explained by assuming a  "surplus" production of a  nonantigen-specific T-cell 1224  IN  SITU  ACTION  OF  T-CELL-REPLACING  FACTOR 
helper factor, presumably TRF, which under the confined conditions of the in 
vitro system bypasses the need for T-B bridging. 
These data are also in agreement with reports on the production of TRF-like 
supernates upon stimulation of T cells educated to KLH (7, 10, 13) or heterolo- 
gous erythrocytes (7,  9) with the respective antigens. Our data demonstrate, 
furthermore, the ability of such a mediator induced by antigen to restore the 
immune response to a soluble protein antigen and show the presence and action 
of this factor in untreated spleen cell cultures from immunized mice without the 
addition of educated T cells. It has been postulated that for the reconstitution of 
the primary  (7) and the secondary (32) immune responses to soluble protein 
antigens in the absence ofT cells, an antigen-specific helper factor is required in 
addition to the nonspecific mediator. In our system, using cells from primed and 
recently boosted mice, this was obviously not the case; the subsequent publica- 
tion (34) will further strengthen this point. 
The concept that the in situ generation of TRF during the anamnestic im- 
mune response to DNPKLH is a function of the KLH-specific helper cells was 
investigated in T-cell depletion and reconstitution experiments (Fig. 5, Table 
II). Indeed, the observed helper effect induced by free carrier for the hapten on a 
heterologous carrier was completely abolished by treatment with anti-Thy 1.2 + 
complement. It could be fully reconstituted by carrier-primed but not by normal 
spleen cells. All these data suggest that during the anamnestic immune re- 
sponses to haptenated soluble protein antigens in vitro, carrier-specific helper 
cells produce a  nonantigen-specific mediator such as TRF,  which can act on 
hapten-specific B  cells that are  stimulated by a  heterologous carrier-hapten 
conjugate. Analogous in vivo experiments have led to conflicting reports. Sev- 
eral authors reported negative results (35, 36). 
On the other hand, Hamaoka et al.  (37) found a  stimulation of anti-hapten 
IgE responses in vivo al~er transfer of DNP Ascaris-primed mouse cells and 
challenge with DNP-KLH in the presence of free Ascaris carrier. A very weak 
anit-hapten IgG response was also observed provided additional Ascaris-primed 
helper cells were transferred. 
The difficulties encountered in the in vivo experiments may be due to diffu- 
sion and/or inactivation of TRF. The conditions for reaching and maintaining 
sufficient local levels of  TRF will be certainly less favorable in vivo than in vitro. 
Nevertheless, the experiments reported in this communication strengthen the 
view that TRF is a physiological signal by which T cells help in the generation of 
antibody-forming cells to T-dependent antigens. 
Alternative explanations cannot as yet be formally excluded. For instance, 
there could be an antigen nonspecific and direct membrane interaction between 
T and B cells. This could be brought about by fortuitous interaction of independ- 
ently stimulated T and B lymphocytes  or by the close proximity of  both cell types 
assembled on a  macrophage. However, our data presented in the subsequent 
publication (34) make this very unlikely. 
Summary 
The involvement of a  nonantigen-specific T-helper factor in the anamnestic 
immune response to dinitrophenyl keyhole limpet hemocyanin is demonstrated TH.  HI)NIG,  A.  SCHIMPL,  AND  E.  WECKER  1225 
employing cultures of unseparated spleen cell populations. In such cultures of 
primed and boosted spleen cells, a  good IgG anti-DNP response could be ob- 
tained if the hapten was presented on a heterologous carrier, provided that the 
homologous carrier was added simultaneously. T-cell depletion and reconstitu- 
tion experiments show that such a  factor, presumably identical with T-cell- 
replacing factor, is produced by primed helper cells upon rechallenge and helps 
primed B cells, stimulated by soluble heterologous carrier hapten conjugates, to 
become IgG-secreting cells. 
We thank Dr. M. Mussgay, BFA fiir  Viruserkrankungen der  Tiere,  Tfibingen,  for  kindly provid- 
ing the horse red blood cells. 
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